| Literature DB >> 28855199 |
Jing Cui1, Ji-Ping Ren1, Dong-Ning Chen1, Zhong Xin2, Ming-Xia Yuan2, Jie Xu3, Qi-Sheng You3, Jin-Kui Yang2.
Abstract
OBJECTIVES: The study aimed to determine the exact risk factors for diabetic retinopathy (DR) in the Chinese population using a cohort of 17 985 individuals from Beijing, China.Entities:
Keywords: China; diabetic retinopathy; fundus examination; prevalence; risk factors
Mesh:
Substances:
Year: 2017 PMID: 28855199 PMCID: PMC5724071 DOI: 10.1136/bmjopen-2016-015473
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Characteristics of the study population
| All | DM | Pre-DM | NGT | |
| Age | 44.1±13.9 | 55.7±11.2*† | 51.4±11.8‡ | 41.8±13.4 |
| Men (%) | 46.2% | 55.5%† | 52.5%‡ | 44.4% |
| BMI (kg/m2) | 24.2±3.1 | 26.3±3.7† | 26.1±3.6‡ | 23.7±3.5 |
| SBP (mm Hg) | 120.9±18.2 | 134.8±20.6† | 134.9±19.8‡ | 117.7±16.1 |
| DBP (mm Hg) | 76.9±11.4 | 83.0±11.8*† | 84.2±11.4‡ | 75.4±10.8 |
| CCR (mL/min) | 99.8±26.4 | 94.1±32.0*† | 96.8±26.4‡ | 100.8±25.5 |
| UA (men) (mmol/L) | 358.6±73.0 | 340.1±79.1*† | 362.2±81.1 | 360.9±70.5 |
| UA (women) (mmol/L) | 265.8±59.3 | 288.5±73.6*† | 278.8±67.1‡ | 262.4±56.3 |
| FPG (mmol/L) | 5.6±1.4 | 8.4±2.6*† | 6.4±0.3‡ | 5.2±0.4 |
| TC (mmol/L) | 4.8±0.9 | 5.0±1.1† | 5.1±1.0‡ | 4.7±0.9 |
| TG (mmol/L) | 1.5±1.3 | 2.2±2.0*† | 1.9±1.4‡ | 1.3±1.2 |
| HDL-C (mmol/L) | 1.3±0.4 | 1.3±0.4*† | 1.3±0.3‡ | 1.3±0.4 |
| LDL-C (mmol/L) | 2.9±0.8 | 2.9±0.8 | 2.9±0.8 | 2.9±0.8 |
| DR | 266/1.5% | 142/8.1%*† | 22/1.4% | 102/0.7% |
| Abdominal obesity | 37.3% | 69.0%*† | 57.9% | 31.3% |
*DM vs pre-DM, p<0.05.
†DM vs NGT, p<0.05.
‡Pre-DM vs NGT, p<0.05.
BMI, body mass index; CCR, creatinine clearance rate; DBP, diastolic blood pressure; DM, diabetes mellitus; DR, diabetic retinopathy; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; NGT, normal glucose tolerance; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides; UA, uric acid.
Comparison of the characteristics between subjects with or without DR
| DR | p Value | ||
| Negative (1608) | Positive (141) | ||
| Age | 55.9±11.3 | 57.1±10.3 | 0.202 |
| Men (%) | 55.5% | 55.6% | 0.979 |
| Diabetes duration | 4.5±4.2 | 7.1±4.6 | <0.001* |
| BMI (kg/m2) | 26.3±3.7 | 25.9±2.9 | 0.090 |
| SBP (mm Hg) | 134.4±20.3 | 139.7±23.2 | 0.007* |
| DBP (mm Hg) | 82.9±11.8 | 82.6±12.2 | 0.757 |
| CCR (mL/min) | 94.5±32.7 | 90.3±27.4 | 0.132 |
| UA (men) (mmol/L) | 341.8±79.6 | 321.4±72.3 | 0.029* |
| UA (women) (mmol/L) | 290.7±73.7 | 263.5±68.9 | 0.005* |
| FPG (mmol/L) | 8.2±2.5 | 10.2±3.4 | <0.001* |
| TC (mmol/L) | 5.0±1.1 | 5.1±1.2 | 0.662 |
| TG (mmol/L) | 2.2±2.1 | 2.2±2.2 | 0.740 |
| HDL-C (mmol/L) | 1.3±0.4 | 1.3±0.3 | 0.486 |
| LDL-C (mmol/L) | 2.9±0.8 | 2.9±0.9 | 0.967 |
| Abdominal obesity (%) | 68.9% | 70.2% | 0.744 |
*p<0.05.
BMI, body mass index; CCR, creatinine clearance rate; DBP, diastolic blood pressure; DM, diabetes mellitus; DR, diabetic retinopathy; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; NGT, normal glucose tolerance; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides; UA, uric acid.
Univariate and multivariate analyses of factors associated with DR in patients with diabetes
| Variables | Univariate | Multivariate | ||
| p Value | OR (95% CI) | p Value | OR (95% CI) | |
| Age (category) | 0.077 | 1.136 (0.972 to 1.328) | 0.270 | 0.882 (0.706 to 1.102) |
| Gender | 0.979 | 1.005 (0.711 to 1.419) | 0.183 | 1.311 (0.880 to 1.952) |
| Duration (category) | <0.001 | 1.503 (1.201 to 1.882) | <0.001 | 1.735 (1.368 to 2.202) |
| BMI (category) | 0.593 | 1.116 (0.747 to 1.666) | 0.046 | 1.579 (1.007 to 2.475) |
| SBP (category) | 0.005 | 1.133 (1.039 to 1.236) | 0.012 | 1.127 (1.027 to 1.238) |
| DBP (category) | 0.644 | 0.965 (0.828 to 1.124) | 0.085 | 0.842 (0.692 to 1.024) |
| CCR (category) | 0.059 | 1.395 (0.987 to 1.972) | 0.014 | 1.613 (1.103 to 2.358) |
| UA | 0.001 | 0.996 (0.994 to 0.998) | 0.018 | 0.997 (0.995 to 0.999) |
| FPG | <0.001 | 1.215 (1.154 to 1.279) | <0.001 | 1.220 (1.152 to 1.291) |
| TC | 0.662 | 1.035 (0.886, 1. 211) | 0.365 | 1.290 (0.744 to 2.239) |
| TG | 0.740 | 0.985 (0.902,1.076) | 0.289 | 0.908 (0.761 to 1.085) |
| HDL-C | 0.486 | 1.188 (0.731,1.931) | 0.687 | 0.836 (0.349 to 2.000) |
| LDL-C | 0.967 | 1.004 (0.819.1.232) | 0.363 | 0.767 (0.434 to 1.357) |
| Abdominal obesity (category) | 0.581 | 1.111 (0.764 to 1.618) | 0.486 | 1.198 (0.721 to 1.992) |
The continuous data were transformed into categorical data: (1) age was divided into 10-year groups; (2) blood pressure was divided into 10 mm Hg groups; (3) the course of the disease was divided into three groups:<5, 5–9 and >9 years; (4) BMI: <24 kg/m2 (normal), >24 kg/m2 (overweight); (5) CCR <90 mL/min (abnormal), CCR >90 mL/min (normal); (6) abdominal obesity: men, waist circumference >85 cm, women, waist circumference of >80 cm, or waist-to-hip ratio >0.93.
BMI, body mass index; CCR, creatinine clearance rate; DBP, diastolic blood pressure; DR, diabetic retinopathy; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides; UA, uric acid.